Showing results (221-230 of 996) with videos related to
Sort By:
Pageof 100
Cancer Research|February 18, 2010
An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signatureAntonis Kourtidis, Ritu Jain, Richard D Carkner, et al.EURASIP Journal on Bioinformatics & Systems Biology|March 5, 2008
MicroRNA target detection and analysis for genes related to breast cancer using MDLcompressScott C Evans, Antonis Kourtidis, T Stephen Markham, et al.Therapeutic Innovation & Regulatory Science|August 31, 2022
The Role of Master Protocols in Pediatric Drug DevelopmentRobert M Nelson, Laurie S Conklin, Wendy J Komocsar, et al.Human Molecular Genetics|June 28, 2020
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boysUtkarsh J Dang, Michael Ziemba, Paula R Clemens, et al.Molecular Cancer Therapeutics|June 4, 2016
Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer CellsXianhui Wang, Jason Wong, Christopher J Sevinsky, et al.RNA Biology|August 4, 2012
RNA science and its applications-a look toward the future: Albany, NY USA, November 3-4, 2011Ronald R Breaker, Douglas S Conklin, Larry Gold, et al.Journal of Bacteriology|August 1, 1980
Regulation of fatty acid degradation in Escherichia coli: dominance studies with strains merodiploid in gene fadRR W Simons, K T Hughes, W D NunnAntimicrobial Agents and Chemotherapy|March 1, 1986
Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilideW T Hughes, B L Smith, D P JacobusThe Journal of Infectious Diseases|October 1, 1994
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal modelW T Hughes, J T Killmar, H S OzNeuroscience Letters|September 28, 1984
Demonstration of substance P immunoreactivity in the nucleus dorsalis of human spinal cordE P Pioro, J T Hughes, A C CuelloPageof 100